Articles by James Calloway
Synopsys Stock Retreats 3.4% as Investors Digest Ansys Integration Costs
Synopsys shares dropped 3.4% Friday, wiping out $3.1 billion in market cap, as investors weighed record Q3 revenue and Ansys integration costs.
Sibanye-Stillwater Soars 216% on H1 Profit Surge
Sibanye-Stillwater ADRs climbed 1.6% after the miner forecast a 216% jump in first-half headline earnings per share, driven by surging gold and platinum-group-metal prices.
Workday Rallies 2.9% as AI Agents Drive Over 25% of New Contract Value
Workday (WDAY) shares climbed 2.9% as AI agents contributed over 25% of new contract value. Subscription revenue grew 13.9%, but free cash flow declined.
Veeva Stock Holds Gains as Q2 Earnings, Margins Impress
Veeva shares hold 14.8% gain post-earnings as Q2 revenue jumps 18% to $928M, with operating margin expanding 480 bps and AI-driven demand. FY guidance raised.
Lilly Stock Slips Despite Mounjaro Heart Approval
Eli Lilly shares dipped 0.9% despite FDA approval for Mounjaro to cut heart risks, as investors had already priced in the news. Sales still surged 91%.
SentinelOne Stock Slides on Reduced Profit Forecast Despite Strong ARR Growth
SentinelOne shares dropped 5.9% premarket after the company lowered its full-year EPS forecast, even as Q2 revenue and ARR grew strongly.
Hormel Shares Plummet 10% on Weak Sales Outlook and Retail Volume Decline
Hormel Foods shares plunged 10% after the company lowered its full-year sales guidance and reported a 9% decline in retail volume, despite an earnings beat.
Autodesk Tumbles on Soft Q3 Profit Forecast Despite Strong Q2
Autodesk shares dropped 4.1% premarket as Q3 profit guidance fell short of expectations, even as Q2 revenue rose 16% and free cash flow grew 24%.
Build-A-Bear Stock Plunges 27% on Slashed Guidance
Build-A-Bear Workshop (BBW) shares plummeted 27.3% to $28.44 after the company slashed its fiscal 2026 outlook, citing weak e-commerce demand and a lost Walmart program.
Best Buy Stock Slides Despite Q2 Beat as Margin Pressures Mount
Best Buy (BBY) shares dropped 4.4% despite a Q2 earnings beat, as rising costs offset profit gains. Revenue grew 3.6% to $9.78B, with comps up 4.1%. FY outlook raised.
Ulta Beauty Stock Slips Despite Q2 Beat and Raised Forecast
Ulta Beauty shares slipped 1.5% premarket even after Q2 results beat estimates and 2026 guidance was raised. Sales grew 8.9% to $3.04B, with EPS of $6.55.
Elastic Stock Soars on $1.85B Backlog, Strong Guidance
Elastic's stock jumped 17.4% premarket as Q1 revenue rose 15% and RPO backlog surged 27%, signaling robust future revenue. Q2 guidance also topped expectations.